Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage

Proteomics

Volumn 8, Issue 22, 2008, Pages 4733-4747

  Baruthio, Frédérique ^a   Quadroni, Manfredo ^b   Rüegg, Curzio ^a   Mariotti, Agnese ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Lipid rafts; Melanoma; Tumor progression

Indexed keywords

CHOLESTEROL; GANGLIOSIDE GD2; GANGLIOSIDE GD3; SPHINGOLIPID;

ARTICLE; BIOINFORMATICS; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELANOMA CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; DETERGENTS; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GANGLIOSIDES; HUMANS; LYMPH NODES; LYMPHOMA; MASS SPECTROMETRY; MELANOMA; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEOMICS; SKIN NEOPLASMS;

EID: 55849147637     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800169     Document Type: Article

References (64)

1. Miller, A. J., Mihm, M. C., Jr., Melanoma. N. Engl. J. Med. 2006, 355, 51-65.
2. Chin, L., Garraway, L. A., Fisher, D. E., Malignant melanoma: Genetics and therapeutics in the genomic era. Genes Dev. 2006, 20, 2149-2182.
3. Haass, N. K., Smalley, K. S., Li, L., Herlyn, M., Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005, 18, 150-159.
4. Herlyn, M., Molecular targets in melanoma: Strategies and challenges for diagnosis and therapy. Int. J. Cancer 2006, 118, 523-526.
5. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y. et al., Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406, 536-540.
6. Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H. et al., Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64, 5270-5282.
7. Meije, C. B., Hakvoort, T. B., Swart, G. W., Westerhof, W. et al., Gene expression patterns in melanocytic cells: Candidate markers for early stage and malignant transformation. J. Pathol. 2002, 196, 51-58.
8. Mischiati, C., Natali, P. G., Sereni, A., Sibilio, L. et al., cDNA-array profiling of melanomas and paired melanocyte cultures. J. Cell. Physiol. 2006, 207, 697-705.
9. Talantov, D., Mazumder, A., Yu, J. X., Briggs, T. et al., Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 2005, 11, 7234-7242.
10. Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J. et al., The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA 2005, 102, 6092-6097.
11. Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P. et al., Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst. 2006, 98, 472-482.
12. Alonso, S. R., Ortiz, P., Pollan, M., Perez-Gomez, B. et al., Progression in cutaneous malignant melanoma is associated with distinct expression profiles: A tissue microarray-based study. Am. J. Pathol. 2004, 164, 193-203.
13. Hancock, J. F., Lipid rafts: Contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 2006, 7, 456-462.
14. London, E., Brown, D. A., Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim. Biophys. Acta 2000, 1508, 182-195.
15. Rajendran, L., Simons, K., Lipid rafts and membrane dynamics. J. Cell Sci. 2005, 118, 1099-1102.
16. Simons, K., Toomre, D., Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
17. Michel, V., Bakovic, M., Lipid rafts in health and disease. Biol. Cell 2007, 99, 129-140.
18. Brusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P. et al., Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. J. Biol. Chem. 2007, 282, 18777-18785.
19. Suprynowicz, F. A., Disbrow, G. L., Krawczyk, E., Simic, V. et al., HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 2008, 27, 1071-1078.
20. Jiang, G., Freywald, T.,Webster, J., Kozan, D. et al., In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes. Mol. Cancer Res. 2008, 6, 291-305.
21. Chinni, S. R., Yamamoto, H., Dong, Z., Sabbota, A. et al., CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol. Cancer Res. 2008, 6, 446-457.
22. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V. et al., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 2008, 10, 619-624.
23. Patra, S. K., Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim. Biophys. Acta 2008, 1785, 182-206.
24. Hsu, M. Y., Shih, D. T., Meier, F. E., Van Belle, P. et al., Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am. J. Pathol. 1998, 153, 1435-1442.
25. Satyamoorthy, K., DeJesus, E., Linnenbach, A. J., Kraj, B. et al., Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 1997, 7, S35-S42.
26. Cornil, I., Theodorescu, D., Man, S., Herlyn, M. et al., Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA 1991, 88, 6028-6032.
27. Herlyn, D., Iliopoulos, D., Jensen, P. J., Parmiter, A. et al., In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res. 1990, 50, 2296-2302.
28. Sprenger, R. R., Speijer, D., Back, J. W., De Koster, C. G. et al., Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 2004, 25, 156-172.
29. Tang, Q., Subudhi, S. K., Henriksen, K. J., Long, C. G. et al., The Src family kinase Fyn mediates signals induced by TCR antagonists. J. Immunol. 2002, 168, 4480-4487.
30. Foster, L. J., De Hoog, C. L.,Mann, M., Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. USA 2003, 100, 5813-5818.
31. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
32. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
33. Li, X. J., Yi, E. C., Kemp, C. J., Zhang, H., Aebersold, R., A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography-mass spectrometry. Mol. Cell. Proteomics 2005, 4, 1328-1340.
34. Palagi, P. M., Walther, D., Quadroni, M., Catherinet, S. et al., MSight: An image analysis software for liquid chromatography-mass spectrometry. Proteomics 2005, 5, 2381-2384.
35. Shogomori, H., Brown, D. A., Use of detergents to study membrane rafts: The good, the bad, and the ugly. Biol. Chem. 2003, 384, 1259-1263.
36. Sprenger, R. R., Horrevoets, A. J., The ins and outs of lipid domain proteomics. Proteomics 2007, 7, 2895-2903.
37. Li, N., Shaw, A. R., Zhang, N., Mak, A., Li, L., Lipid raft proteomics: Analysis of in-solution digest of sodium dodecyl sulfate-solubilized lipid raft proteins by liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry. Proteomics 2004, 4, 3156-3166.
38. Nebl, T., Pestonjamasp, K. N., Leszyk, J. D., Crowley, J. L. et al., Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasmamembranes. J. Biol. Chem. 2002, 277, 43399-43409.
39. von Haller, P. D., Donohoe, S., Goodlett, D. R., Aebersold, R., Watts, J. D., Mass spectrometric characterization of proteins extracted from Jurkat T cell detergent-resistant membrane domains. Proteomics 2001, 1, 1010-1021.
40. Ishihama, Y., Oda, Y., Tabata, T., Sato, T. et al., Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4, 1265-1272.
41. Liu, H., Sadygov, R. G., Yates, J. R., III, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
42. Hakomori, S., Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56, 5309-5318.
43. Rossier-Pansier, L., Baruthio, F., Ruegg, C., Mariotti, A., J. Cell. Biochem. 2008, 103, 957-971.
44. Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., Gillies, R. J., Vacuolar-type H(1)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 1993, 265, C1015-C1029.
45. Martinez-Zaguilan, R., Martinez, G. M., Gomez, A., Hendrix, M. J., Gillies, R. J., Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential. J. Cell. Physiol. 1998, 176, 196-205.
46. Martinez-Zaguilan, R., Raghunand, N., Lynch, R. M., Bellamy, W. et al., pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem. Pharmacol. 1999, 57, 1037-1046.
47. Sennoune, S. R., Bakunts, K., Martinez, G. M., Chua-Tuan, J. L. et al., Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: Distribution and functional activity. Am. J. Physiol., Cell Physiol. 2004, 286, C1443-C1452.
48. Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H. et al., Cellular pH regulators: Potentially promising molecular targets for cancer chemotherapy. Cancer Treat. Rev. 2003, 29, 541-549.
49. Sprenger, R. R., Fontijn, R. D., van Marle, J., Pannekoek, H., Horrevoets, A. J., Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. Biochem. J. 2006, 400, 401-410.
50. Yoshinaka, K., Kumanogoh, H., Nakamura, S., Maekawa, S., Identification of V-ATPase as a major component in the raft fraction prepared from the synaptic plasma membrane and the synaptic vesicle of rat brain. Neurosci. Lett. 2004, 363, 168-172.
51. Lee, S. W., H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 1996, 2, 776-782.
52. Mukoyama, Y., Zhou, S., Miyachi, Y., Matsuyoshi, N., T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J. Invest. Dermatol. 2005, 124, 833-838.
53. Takeuchi, T., Liang, S. B., Ohtsuki, Y., Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol. Carcinog. 2002, 35, 173-179.
54. Toyooka, K. O., Toyooka, S., Virmani, A. K., Sathyanarayana, U. G. et al., Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 2001, 61, 4556-4560.
55. Nakashima, H., Hamamura, K., Houjou, T., Taguchi, R. et al., Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties. Cancer Sci. 2007, 98, 512-520.
56. Doherty, S. D., Prieto, V. G., George, S., Hazarika, P., Duvic, M., High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 2006, 16, 461-463.
57. Hazarika, P., McCarty, M. F., Prieto, V. G., George, S. et al., Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 2004, 64, 7361-7369.
58. Tinari, N., Kuwabara, I., Huflejt, M. E., Shen, P. F. et al., Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int. J. Cancer 2001, 91, 167-172.
59. Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A. et al., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004, 5, 241-251.
60. Radhika, V., Onesime, D., Ha, J. H., Dhanasekaran, N., Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J. Biol. Chem. 2004, 279, 49406-49413.
61. Shan, D., Chen, L.,Wang, D., Tan, Y. C. et al., The G protein G alpha(13) is required for growth factor-induced cell migration. Dev. Cell 2006, 10, 707-718.
62. Tan, W., Martin, D., Gutkind, J. S., The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J. Biol. Chem. 2006, 281, 39542-39549.
63. Kelly, P., Moeller, B. J., Juneja, J., Booden, M. A. et al., The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc. Natl. Acad. Sci. USA 2006, 103, 8173-8178.
64. Kelly, P., Stemmle, L. N., Madden, J. F., Fields, T. A. et al., A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J. Biol. Chem. 2006, 281, 26483-26490.